Francisco E Estévez-Carrizo

Learn More
BACKGROUND Quetiapine is a dibenzothiazepine derivative that has been established as an effective therapy for schizophrenia and bipolar disorder. A new extended-release (XR) solid formulation of(More)
OBJECTIVE To assess the bioequivalence and safety of a new formulation of mycophenolate mofetil (MMF) 500 mg (Suprimun®, Clausen, Montevideo, Uruguay) marketed in Uruguay and other South American(More)
BACKGROUND Imatinib is a tyrosine kinase inhibitor that has been established as a highly effective therapy for chronic myelogenous leukemia and gastrointestinal stromal tumors. A new generic,(More)
  • 1